Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 40 entries
Sorted by: Best Match Show Resources per page
Metronomic chemotherapy in anaplastic thyroid carcinoma: a potentially feasible alternative to therapeutic nihilism.

Indian journal of palliative care

Revannasiddaiah S, Madabhavi I, Bodh A, Thakur P, Sharma M.
PMID: 26009682
Indian J Palliat Care. 2015 May-Aug;21(2):245-9. doi: 10.4103/0973-1075.156511.

Anaplastic thyroid carcinoma (ATC) is one of the most aggressive malignancies and prognostic outlook remains very dismal. Treatment most often is palliative in intent attempting to relieve the patients from local compressive symptoms in the neck. Radical surgery, radiotherapy...

Cite
Revannasiddaiah S, Madabhavi I, Bodh A, et al. Metronomic chemotherapy in anaplastic thyroid carcinoma: a potentially feasible alternative to therapeutic nihilism. Indian J Palliat Care. 2015;21(2):245-9doi: 10.4103/0973-1075.156511.
Revannasiddaiah, S., Madabhavi, I., Bodh, A., Thakur, P., & Sharma, M. (2015). Metronomic chemotherapy in anaplastic thyroid carcinoma: a potentially feasible alternative to therapeutic nihilism. Indian journal of palliative care, 21(2), 245-9. https://doi.org/10.4103/0973-1075.156511
Revannasiddaiah, Swaroop, et al. "Metronomic chemotherapy in anaplastic thyroid carcinoma: a potentially feasible alternative to therapeutic nihilism." Indian journal of palliative care vol. 21,2 (2015): 245-9. doi: https://doi.org/10.4103/0973-1075.156511
Revannasiddaiah S, Madabhavi I, Bodh A, Thakur P, Sharma M. Metronomic chemotherapy in anaplastic thyroid carcinoma: a potentially feasible alternative to therapeutic nihilism. Indian J Palliat Care. 2015 May-Aug;21(2):245-9. doi: 10.4103/0973-1075.156511. PMID: 26009682; PMCID: PMC4441190.
Copy Download .nbib Format: NLM
Primary Mediastinal Synovial Sarcoma Presenting as Superior Vena Cava Syndrome: A Rare Case Report and Review of the Literature.

Case reports in oncological medicine

Madabhavi I, Kataria P, Patel A, Revannasiddaiah S, Anand A, Panchal H, Parikh S, Sarkar M, Modi G, Kulkarni R, Shah S.
PMID: 26101678
Case Rep Oncol Med. 2015;2015:651813. doi: 10.1155/2015/651813. Epub 2015 May 25.

Primary mediastinal sarcomas are aggressive tumors with a very rare incidence. This report describes the case of a 35-year-old male patient who presented with acute symptoms of dyspnoea, facial puffiness, voice-hoarseness, and engorged neck veins. With the clinical picture...

Cite
Madabhavi I, Kataria P, Patel A, et al. Primary Mediastinal Synovial Sarcoma Presenting as Superior Vena Cava Syndrome: A Rare Case Report and Review of the Literature. Case Rep Oncol Med. 2015;2015:651813doi: 10.1155/2015/651813.
Madabhavi, I., Kataria, P., Patel, A., Revannasiddaiah, S., Anand, A., Panchal, H., Parikh, S., Sarkar, M., Modi, G., Kulkarni, R., & Shah, S. (2015). Primary Mediastinal Synovial Sarcoma Presenting as Superior Vena Cava Syndrome: A Rare Case Report and Review of the Literature. Case reports in oncological medicine, 2015651813. https://doi.org/10.1155/2015/651813
Madabhavi, Irappa, et al. "Primary Mediastinal Synovial Sarcoma Presenting as Superior Vena Cava Syndrome: A Rare Case Report and Review of the Literature." Case reports in oncological medicine vol. 2015 (2015): 651813. doi: https://doi.org/10.1155/2015/651813
Madabhavi I, Kataria P, Patel A, Revannasiddaiah S, Anand A, Panchal H, Parikh S, Sarkar M, Modi G, Kulkarni R, Shah S. Primary Mediastinal Synovial Sarcoma Presenting as Superior Vena Cava Syndrome: A Rare Case Report and Review of the Literature. Case Rep Oncol Med. 2015;2015:651813. doi: 10.1155/2015/651813. Epub 2015 May 25. PMID: 26101678; PMCID: PMC4458531.
Copy Download .nbib Format: NLM
Chemically enhanced radiotherapy: visions for the future.

Annals of translational medicine

Revannasiddaiah S, Susheela SP.
PMID: 26904574
Ann Transl Med. 2016 Feb;4(3):52. doi: 10.3978/j.issn.2305-5839.2015.11.06.

Radiotherapy (RT) is an important part of cancer management, with more than a third of all cancer cures being attributable to RT. Despite the advances in RT over the past century, the overall outcomes in a majority of malignancies...

Cite
Revannasiddaiah S, Susheela SP. Chemically enhanced radiotherapy: visions for the future. Ann Transl Med. 2016;4(3):52doi: 10.3978/j.issn.2305-5839.2015.11.06.
Revannasiddaiah, S., & Susheela, S. P. (2016). Chemically enhanced radiotherapy: visions for the future. Annals of translational medicine, 4(3), 52. https://doi.org/10.3978/j.issn.2305-5839.2015.11.06
Revannasiddaiah, Swaroop, and Susheela, Sridhar P. "Chemically enhanced radiotherapy: visions for the future." Annals of translational medicine vol. 4,3 (2016): 52. doi: https://doi.org/10.3978/j.issn.2305-5839.2015.11.06
Revannasiddaiah S, Susheela SP. Chemically enhanced radiotherapy: visions for the future. Ann Transl Med. 2016 Feb;4(3):52. doi: 10.3978/j.issn.2305-5839.2015.11.06. PMID: 26904574; PMCID: PMC4740004.
Copy Download .nbib Format: NLM
Radiotherapy to volumes defined by metabolic imaging in gliomas: time to abandon monstrous margins?.

Annals of translational medicine

Susheela SP, Revannasiddaiah S.
PMID: 26904577
Ann Transl Med. 2016 Feb;4(3):55. doi: 10.3978/j.issn.2305-5839.2016.01.19.

The survival in patients with high grade gliomas (HGG) remains poor even after the adoption post-operative radiotherapy (RT) to magnetic resonance imaging (MRI) based volumes. Despite delivery of 'standardized' doses of radiation, recurrence is the norm, rather than the...

Cite
Susheela SP, Revannasiddaiah S. Radiotherapy to volumes defined by metabolic imaging in gliomas: time to abandon monstrous margins?. Ann Transl Med. 2016;4(3):55doi: 10.3978/j.issn.2305-5839.2016.01.19.
Susheela, S. P., & Revannasiddaiah, S. (2016). Radiotherapy to volumes defined by metabolic imaging in gliomas: time to abandon monstrous margins?. Annals of translational medicine, 4(3), 55. https://doi.org/10.3978/j.issn.2305-5839.2016.01.19
Susheela, Sridhar P, and Revannasiddaiah, Swaroop. "Radiotherapy to volumes defined by metabolic imaging in gliomas: time to abandon monstrous margins?." Annals of translational medicine vol. 4,3 (2016): 55. doi: https://doi.org/10.3978/j.issn.2305-5839.2016.01.19
Susheela SP, Revannasiddaiah S. Radiotherapy to volumes defined by metabolic imaging in gliomas: time to abandon monstrous margins?. Ann Transl Med. 2016 Feb;4(3):55. doi: 10.3978/j.issn.2305-5839.2016.01.19. PMID: 26904577; PMCID: PMC4740003.
Copy Download .nbib Format: NLM
Primary Hepatic Burkitt Lymphoma: A Bizarre Site and Triumph Tale.

Journal of clinical and experimental hepatology

Modi G, Madabhavi I, Patel A, Revannasiddaiah S, Anand A, Panchal H, Parikh S, Baldaniya K.
PMID: 26155044
J Clin Exp Hepatol. 2015 Jun;5(2):159-62. doi: 10.1016/j.jceh.2015.05.002. Epub 2015 May 21.

Primary hepatic Burkitt lymphoma (PHBL) is an extremely rare form extra nodal lymphoma and till now only 11 case reports have been found in the literature. We are reporting an adult female with primary hepatic Burkitt's lymphoma, who achieved...

Cite
Modi G, Madabhavi I, Patel A, et al. Primary Hepatic Burkitt Lymphoma: A Bizarre Site and Triumph Tale. J Clin Exp Hepatol. 2015;5(2):159-62doi: 10.1016/j.jceh.2015.05.002.
Modi, G., Madabhavi, I., Patel, A., Revannasiddaiah, S., Anand, A., Panchal, H., Parikh, S., & Baldaniya, K. (2015). Primary Hepatic Burkitt Lymphoma: A Bizarre Site and Triumph Tale. Journal of clinical and experimental hepatology, 5(2), 159-62. https://doi.org/10.1016/j.jceh.2015.05.002
Modi, Gaurang, et al. "Primary Hepatic Burkitt Lymphoma: A Bizarre Site and Triumph Tale." Journal of clinical and experimental hepatology vol. 5,2 (2015): 159-62. doi: https://doi.org/10.1016/j.jceh.2015.05.002
Modi G, Madabhavi I, Patel A, Revannasiddaiah S, Anand A, Panchal H, Parikh S, Baldaniya K. Primary Hepatic Burkitt Lymphoma: A Bizarre Site and Triumph Tale. J Clin Exp Hepatol. 2015 Jun;5(2):159-62. doi: 10.1016/j.jceh.2015.05.002. Epub 2015 May 21. PMID: 26155044; PMCID: PMC4491635.
Copy Download .nbib Format: NLM
4-(4-Methyl-phen-yl)-2-(prop-2-yn-1-yl)phthalazin-1(2H)-one.

Acta crystallographica. Section E, Structure reports online

Usha MK, Madan Kumar S, Shyma PC, Kalluraya B, Lokanath NK, Revannasiddaiah D.
PMID: 24764864
Acta Crystallogr Sect E Struct Rep Online. 2014 Jan 15;70:o138. doi: 10.1107/S1600536813034880. eCollection 2014 Feb 01.

In the title compound, C18H14N2O, the dihedral angle between the methyl-phenyl ring and the phthalazone ring system (r.m.s. deviation = 0.034 Å) is 53.93 (9)°. In the crystal, mol-ecules are connected by C-H⋯O hydrogen bonds, forming chains along [101]....

Cite
Usha MK, Madan Kumar S, Shyma PC, et al. 4-(4-Methyl-phen-yl)-2-(prop-2-yn-1-yl)phthalazin-1(2H)-one. Acta Crystallogr Sect E Struct Rep Online. 2014;70:o138doi: 10.1107/S1600536813034880.
Usha, M. K., Madan Kumar, S., Shyma, P. C., Kalluraya, B., Lokanath, N. K., & Revannasiddaiah, D. (2014). 4-(4-Methyl-phen-yl)-2-(prop-2-yn-1-yl)phthalazin-1(2H)-one. Acta crystallographica. Section E, Structure reports online, 70o138. https://doi.org/10.1107/S1600536813034880
Usha, M K, et al. "4-(4-Methyl-phen-yl)-2-(prop-2-yn-1-yl)phthalazin-1(2H)-one." Acta crystallographica. Section E, Structure reports online vol. 70 (2014): o138. doi: https://doi.org/10.1107/S1600536813034880
Usha MK, Madan Kumar S, Shyma PC, Kalluraya B, Lokanath NK, Revannasiddaiah D. 4-(4-Methyl-phen-yl)-2-(prop-2-yn-1-yl)phthalazin-1(2H)-one. Acta Crystallogr Sect E Struct Rep Online. 2014 Jan 15;70:o138. doi: 10.1107/S1600536813034880. eCollection 2014 Feb 01. PMID: 24764864; PMCID: PMC3998303.
Copy Download .nbib Format: NLM
HAART and ATT in the HIV-positive patient with tuberculosis.

Lung India : official organ of Indian Chest Society

Jhiens ZZ, Revannasiddaiah S.
PMID: 22628949
Lung India. 2012 Apr;29(2):196-7. doi: 10.4103/0970-2113.95349.

No abstract available.

Cite
Jhiens ZZ, Revannasiddaiah S. HAART and ATT in the HIV-positive patient with tuberculosis. Lung India. 2012;29(2):196-7doi: 10.4103/0970-2113.95349.
Jhiens, Z. Z., & Revannasiddaiah, S. (2012). HAART and ATT in the HIV-positive patient with tuberculosis. Lung India : official organ of Indian Chest Society, 29(2), 196-7. https://doi.org/10.4103/0970-2113.95349
Jhiens, Zi Z, and Revannasiddaiah, Swaroop. "HAART and ATT in the HIV-positive patient with tuberculosis." Lung India : official organ of Indian Chest Society vol. 29,2 (2012): 196-7. doi: https://doi.org/10.4103/0970-2113.95349
Jhiens ZZ, Revannasiddaiah S. HAART and ATT in the HIV-positive patient with tuberculosis. Lung India. 2012 Apr;29(2):196-7. doi: 10.4103/0970-2113.95349. PMID: 22628949; PMCID: PMC3354508.
Copy Download .nbib Format: NLM
Painless lump over the forehead which turned painful: an unusual presentation of hepatocellular carcinoma.

BJR case reports

Susheela SP, Revannasiddaiah S, Basavalingaiah AS, Madabhavi I.
PMID: 30363169
BJR Case Rep. 2015 May 18;1(2):20150033. doi: 10.1259/bjrcr.20150033. eCollection 2015.

Hepatocellular carcinoma (HCC) is one of the most common malignancies and is known to most often present with symptomatology pertaining to local hepatic disease. Although HCC is known to metastasize to lungs, abdominal lymph nodes, adrenal glands and the...

Cite
Susheela SP, Revannasiddaiah S, Basavalingaiah AS, et al. Painless lump over the forehead which turned painful: an unusual presentation of hepatocellular carcinoma. BJR Case Rep. 2015;1(2):20150033doi: 10.1259/bjrcr.20150033.
Susheela, S. P., Revannasiddaiah, S., Basavalingaiah, A. S., & Madabhavi, I. (2015). Painless lump over the forehead which turned painful: an unusual presentation of hepatocellular carcinoma. BJR case reports, 1(2), 20150033. https://doi.org/10.1259/bjrcr.20150033
Susheela, S P, et al. "Painless lump over the forehead which turned painful: an unusual presentation of hepatocellular carcinoma." BJR case reports vol. 1,2 (2015): 20150033. doi: https://doi.org/10.1259/bjrcr.20150033
Susheela SP, Revannasiddaiah S, Basavalingaiah AS, Madabhavi I. Painless lump over the forehead which turned painful: an unusual presentation of hepatocellular carcinoma. BJR Case Rep. 2015 May 18;1(2):20150033. doi: 10.1259/bjrcr.20150033. eCollection 2015. PMID: 30363169; PMCID: PMC6159124.
Copy Download .nbib Format: NLM
1-[5-Methyl-1-(4-nitro-phen-yl)-1H-1,2,3-triazol-4-yl]ethanone.

Acta crystallographica. Section E, Structure reports online

Vinutha N, Madan Kumar S, Nithinchandra, Balakrishna K, Lokanath NK, Revannasiddaiah D.
PMID: 24454146
Acta Crystallogr Sect E Struct Rep Online. 2013 Oct 31;69:o1724. doi: 10.1107/S1600536813029425. eCollection 2013 Oct 31.

The asymmetric unit of the title compound, C11H10N4O3, contains two independent mol-ecules in which the benzene rings make dihedral angles of 38.3 (2) and 87.1 (2)° with respect to the triazole rings. In the crystal, the mol-ecules are linked...

Cite
Vinutha N, Madan Kumar S, Nithinchandra, et al. 1-[5-Methyl-1-(4-nitro-phen-yl)-1H-1,2,3-triazol-4-yl]ethanone. Acta Crystallogr Sect E Struct Rep Online. 2013;69:o1724doi: 10.1107/S1600536813029425.
Vinutha, N., Madan Kumar, S., Nithinchandra, Balakrishna, K., Lokanath, N. K., & Revannasiddaiah, D. (2013). 1-[5-Methyl-1-(4-nitro-phen-yl)-1H-1,2,3-triazol-4-yl]ethanone. Acta crystallographica. Section E, Structure reports online, 69o1724. https://doi.org/10.1107/S1600536813029425
Vinutha, N, et al. "1-[5-Methyl-1-(4-nitro-phen-yl)-1H-1,2,3-triazol-4-yl]ethanone." Acta crystallographica. Section E, Structure reports online vol. 69 (2013): o1724. doi: https://doi.org/10.1107/S1600536813029425
Vinutha N, Madan Kumar S, Nithinchandra, Balakrishna K, Lokanath NK, Revannasiddaiah D. 1-[5-Methyl-1-(4-nitro-phen-yl)-1H-1,2,3-triazol-4-yl]ethanone. Acta Crystallogr Sect E Struct Rep Online. 2013 Oct 31;69:o1724. doi: 10.1107/S1600536813029425. eCollection 2013 Oct 31. PMID: 24454146; PMCID: PMC3884370.
Copy Download .nbib Format: NLM
Dimethyl 2-[2-(2,4,6-tri-chloro-phen-yl)hydrazin-1-yl-idene]butane-dioate.

Acta crystallographica. Section E, Structure reports online

Usha MK, Shetty S, Kalluraya B, Kant R, Gupta VK, Revannasiddaiah D.
PMID: 24526964
Acta Crystallogr Sect E Struct Rep Online. 2013 Dec 04;70:o13. doi: 10.1107/S160053681303242X. eCollection 2014 Jan 01.

In the title compound, C12H11Cl3N2O4, the dihedral angle between the aromatic ring and the hydrazine (NH-N=C) grouping is 52.2 (3)°. The butanedioate groups exhibit planar conformations. An intra-molecular N-H⋯O hydrogen bond links the N-H group of the hydrazine to...

Cite
Usha MK, Shetty S, Kalluraya B, et al. Dimethyl 2-[2-(2,4,6-tri-chloro-phen-yl)hydrazin-1-yl-idene]butane-dioate. Acta Crystallogr Sect E Struct Rep Online. 2013;70:o13doi: 10.1107/S160053681303242X.
Usha, M. K., Shetty, S., Kalluraya, B., Kant, R., Gupta, V. K., & Revannasiddaiah, D. (2014). Dimethyl 2-[2-(2,4,6-tri-chloro-phen-yl)hydrazin-1-yl-idene]butane-dioate. Acta crystallographica. Section E, Structure reports online, 70o13. https://doi.org/10.1107/S160053681303242X
Usha, M K, et al. "Dimethyl 2-[2-(2,4,6-tri-chloro-phen-yl)hydrazin-1-yl-idene]butane-dioate." Acta crystallographica. Section E, Structure reports online vol. 70 (2014): o13. doi: https://doi.org/10.1107/S160053681303242X
Usha MK, Shetty S, Kalluraya B, Kant R, Gupta VK, Revannasiddaiah D. Dimethyl 2-[2-(2,4,6-tri-chloro-phen-yl)hydrazin-1-yl-idene]butane-dioate. Acta Crystallogr Sect E Struct Rep Online. 2013 Dec 04;70:o13. doi: 10.1107/S160053681303242X. eCollection 2014 Jan 01. PMID: 24526964; PMCID: PMC3914063.
Copy Download .nbib Format: NLM
1-{3-(4-Methyl-phen-yl)-5-[5-(2-nitro-phen-yl)furan-2-yl]-4,5-di-hydro-1H-pyrazol-1-yl}ethanone.

Acta crystallographica. Section E, Structure reports online

Vinutha N, Madan Kumar S, Vidyashree Jois BS, Balakrishna K, Lokanath NK, Revannasiddaiah D.
PMID: 24098216
Acta Crystallogr Sect E Struct Rep Online. 2013 Sep 12;69:o1528. doi: 10.1107/S1600536813024690. eCollection 2013.

In the title compound, C22H19N3O4, the dihedral angle between the furan and pyrazole rings is 82.73 (19)° while the dihedral angles between the furan and pyrazole rings and their attached benzene rings are 31.93 (18) and 1.88 (18)°, respectively....

Cite
Vinutha N, Madan Kumar S, Vidyashree Jois BS, et al. 1-{3-(4-Methyl-phen-yl)-5-[5-(2-nitro-phen-yl)furan-2-yl]-4,5-di-hydro-1H-pyrazol-1-yl}ethanone. Acta Crystallogr Sect E Struct Rep Online. 2013;69:o1528doi: 10.1107/S1600536813024690.
Vinutha, N., Madan Kumar, S., Vidyashree Jois, B. S., Balakrishna, K., Lokanath, N. K., & Revannasiddaiah, D. (2013). 1-{3-(4-Methyl-phen-yl)-5-[5-(2-nitro-phen-yl)furan-2-yl]-4,5-di-hydro-1H-pyrazol-1-yl}ethanone. Acta crystallographica. Section E, Structure reports online, 69o1528. https://doi.org/10.1107/S1600536813024690
Vinutha, N, et al. "1-{3-(4-Methyl-phen-yl)-5-[5-(2-nitro-phen-yl)furan-2-yl]-4,5-di-hydro-1H-pyrazol-1-yl}ethanone." Acta crystallographica. Section E, Structure reports online vol. 69 (2013): o1528. doi: https://doi.org/10.1107/S1600536813024690
Vinutha N, Madan Kumar S, Vidyashree Jois BS, Balakrishna K, Lokanath NK, Revannasiddaiah D. 1-{3-(4-Methyl-phen-yl)-5-[5-(2-nitro-phen-yl)furan-2-yl]-4,5-di-hydro-1H-pyrazol-1-yl}ethanone. Acta Crystallogr Sect E Struct Rep Online. 2013 Sep 12;69:o1528. doi: 10.1107/S1600536813024690. eCollection 2013. PMID: 24098216; PMCID: PMC3790397.
Copy Download .nbib Format: NLM
Regarding the study testing the addition of gemcitabine to concurrent chemoradiotherapy in cervical carcinoma: Clarity needed.

Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology

Revannasiddaiah S, Rastogi M, Gupta M, Seam R.
PMID: 23878493
Indian J Med Paediatr Oncol. 2013 Jan;34(1):50. doi: 10.4103/0971-5851.113436.

No abstract available.

Cite
Revannasiddaiah S, Rastogi M, Gupta M, et al. Regarding the study testing the addition of gemcitabine to concurrent chemoradiotherapy in cervical carcinoma: Clarity needed. Indian J Med Paediatr Oncol. 2013;34(1):50doi: 10.4103/0971-5851.113436.
Revannasiddaiah, S., Rastogi, M., Gupta, M., & Seam, R. (2013). Regarding the study testing the addition of gemcitabine to concurrent chemoradiotherapy in cervical carcinoma: Clarity needed. Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology, 34(1), 50. https://doi.org/10.4103/0971-5851.113436
Revannasiddaiah, Swaroop, et al. "Regarding the study testing the addition of gemcitabine to concurrent chemoradiotherapy in cervical carcinoma: Clarity needed." Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology vol. 34,1 (2013): 50. doi: https://doi.org/10.4103/0971-5851.113436
Revannasiddaiah S, Rastogi M, Gupta M, Seam R. Regarding the study testing the addition of gemcitabine to concurrent chemoradiotherapy in cervical carcinoma: Clarity needed. Indian J Med Paediatr Oncol. 2013 Jan;34(1):50. doi: 10.4103/0971-5851.113436. PMID: 23878493; PMCID: PMC3715985.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 40 entries